{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:35:43Z","timestamp":1778200543616,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019108","name":"National Chemical Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ZX1916C"],"award-info":[{"award-number":["01ZX1916C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymgme.2024.108489","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:45:50Z","timestamp":1714751150000},"page":"108489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS\/MS neonatal screening method for the diagnosis of Canavan disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Christian","family":"Posern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Santer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Bley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Murko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108489_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13023-020-01659-3","article-title":"The natural history of Canavan disease: 23 new cases and comparison with patients from literature","volume":"16","author":"Bley","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108489_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.02.069","article-title":"Mutational analysis of aspartoacylase: implications for Canavan disease","volume":"1148","author":"Hershfield","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2024.108489_bb0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.23181","article-title":"Clinically distinct phenotypes of Canavan disease correlate with residual aspartoacylase enzyme activity","volume":"38","author":"Mendes","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2024.108489_bb0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00706-018-2349-x","article-title":"LC-MS\/MS determination of N-acetylaspartic acid in dried blood spot for selective screening of Canavan disease","volume":"150","author":"Jurd\u00e1kov\u00e1","year":"2019","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ymgme.2024.108489_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymgme.2024.108489_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00726-001-0144-0","article-title":"In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration","volume":"23","author":"Block","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.ymgme.2024.108489_bb0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nic.2012.10.002","article-title":"Brain proton magnetic resonance spectroscopy: introduction and overview","volume":"23","author":"Bertholdo","year":"2013","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.ymgme.2024.108489_bb0040","series-title":"GeneReviews [Internet]","first-page":"1993","article-title":"Canavan disease","author":"Matalon","year":"2024"},{"key":"10.1016\/j.ymgme.2024.108489_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661928","article-title":"Canavan disease as a model for gene therapy-mediated myelin repair","volume":"15","author":"Lotun","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymgme.2024.108489_bb0050","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0005-2760(68)90101-X","article-title":"Acetyl transport mechanisms. Metabolism of N-acetyl-l-aspartic acid in the non-nervous tissues of the rat","volume":"152","author":"Benuck","year":"1968","journal-title":"Biochim. Biophys. Acta Lipids Lipid Metab."},{"key":"10.1016\/j.ymgme.2024.108489_bb0055","doi-asserted-by":"crossref","first-page":"36040","DOI":"10.1074\/jbc.M113.491324","article-title":"NAT8L (N-acetyltransferase 8-like) accelerates lipid turnover and increases energy expenditure in brown adipocytes","volume":"288","author":"Pessentheiner","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108489_bb0060","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1073\/pnas.0409184102","article-title":"Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan\u2019s disease","volume":"102","author":"Madhavarao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2024.108489_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbamcr.2018.08.017","article-title":"N-acetylaspartate pathway is nutrient responsive and coordinates lipid and energy metabolism in brown adipocytes","volume":"1866","author":"Huber","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.ymgme.2024.108489_bb0070","doi-asserted-by":"crossref","first-page":"23723","DOI":"10.1038\/srep23723","article-title":"N-acetylaspartate catabolism determines cytosolic acetyl-CoA levels and histone acetylation in brown adipocytes","volume":"6","author":"Prokesch","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2024.108489_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molcel.2006.05.040","article-title":"Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription","volume":"23","author":"Takahashi","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgme.2024.108489_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnene.2013.00011","article-title":"N-acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation","volume":"5","author":"Moffett","year":"2013","journal-title":"Front. Neuroenerg."},{"key":"10.1016\/j.ymgme.2024.108489_bb0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijdevneu.2007.04.002","article-title":"N-acetylaspartic acid promotes oxidative stress in cerebral cortex of rats","volume":"25","author":"Pederzolli","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ymgme.2024.108489_bb0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11011-009-9137-6","article-title":"Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats","volume":"24","author":"Pederzolli","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2024.108489_bb0095","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1046\/j.1471-4159.2000.0742512.x","article-title":"Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system","volume":"74","author":"Kitada","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2024.108489_bb0100","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awp087","article-title":"The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes","volume":"132","author":"Ko\u0142odziejczyk","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2024.108489_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0197-0186(01)00095-X","article-title":"Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system: an analytical review","volume":"40","author":"Baslow","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymgme.2024.108489_bb0110","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11064-009-9958-z","article-title":"Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiformleukodystrophy in Canavan disease?","volume":"34","author":"Baslow","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2024.108489_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for Canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2024.108489_bb0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2016.10.001","article-title":"N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase","volume":"96","author":"Francis","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2024.108489_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90807","article-title":"Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease","volume":"2","author":"Gessler","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2024.108489_bb0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2021.01.009","article-title":"Preclinical biodistribution, tropism, and efficacy of oligotropic AAV\/Olig001 in a mouse model of congenital white matter disease","volume":"20","author":"Francis","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2024.108489_bb0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2024.108489_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208755","article-title":"Early diagnosis of Canavan syndrome: how can we get there?","author":"De Bernardo","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2024.108489_bb0145","first-page":"572","article-title":"The molecular basis of Canavan (aspartoacylase deficiency) disease in European non-Jewish patients","volume":"57","author":"Shaag","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2024.108489_bb0150","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41436-020-0790-9","article-title":"A highly multiplexed biochemical assay for analytes in dried blood spots: application to newborn screening and diagnosis of lysosomal storage disorders and other inborn errors of metabolism","volume":"22","author":"Hong","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2024.108489_bb0155","first-page":"34","article-title":"Canavan disease: mutations among Jewish and non-Jewish patients","volume":"55","author":"Kaul","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2024.108489_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/ejpn.1999.0256","article-title":"Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease","volume":"4","author":"Rady","year":"2000","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108489_bb0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ymgme.2006.05.014","article-title":"Rapid detection of three large novel deletions of the aspartoacylase gene in non-Jewish patients with Canavan disease","volume":"89","author":"Zeng","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108489_bb0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.ejhg.5200477","article-title":"Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population","volume":"8","author":"Sistermans","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2024.108489_bb0175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/08830738030180111601","article-title":"Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem","volume":"18","author":"Surendran","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2024.108489_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng1093-118","article-title":"Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease","volume":"5","author":"Kaul","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2024.108489_bb0185","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.20787","article-title":"Mild-onset presentation of Canavan\u2019s disease associated with novel G212A point mutation in aspartoacylase gene","volume":"59","author":"Janson","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2024.108489_bb0190","first-page":"95","article-title":"Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease","volume":"59","author":"Kaul","year":"1996","journal-title":"Am. J. Hum. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T21:38:58Z","timestamp":1716845938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224003731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1096719224003731"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108489","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS\/MS neonatal screening method for the diagnosis of Canavan disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108489"}}